Adaptive Biotechnologies Corp - Common Stock (ADPT)

CUSIP: 00650F109

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
151,803,139
Total 13F shares
150,280,907
Share change
+1,522,414
Total reported value
$2,440,621,109
Put/Call ratio
58%
Price per share
$16.24
Number of holders
281
Value change
+$33,872,592
Number of buys
144
Number of sells
130

Quarterly Holders Quick Answers

What is CUSIP 00650F109?
CUSIP 00650F109 identifies ADPT - Adaptive Biotechnologies Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q4 2025

As of 31 Dec 2025, Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by 281 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 150,280,907 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, BlackRock, Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, WESTFIELD CAPITAL MANAGEMENT CO LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Invesco Ltd., LORD, ABBETT & CO. LLC, and GOLDMAN SACHS GROUP INC. This page lists 281 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.